Form 4: Moderna CFO James Mock Reports Stock Transactions
SEC Form 4 Filing
Chief Financial Officer of Moderna, James Mock, reports the acquisition and disposal of company stock and restricted stock units on April 4, 2025.
Summary
- James Mock, the Chief Financial Officer of Moderna, filed a Form 4 detailing changes in beneficial ownership of the company's securities.
- On April 4, 2025, Mock exercised restricted stock units, converting 1,452 units into common stock.
- Also on April 4, 2025, Mock disposed of 703 shares of common stock at a price of $25.73 to cover tax withholding obligations.
- Following these transactions, Mock directly owns 15,623 shares of Moderna common stock and 8,717 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral filing reflecting standard executive compensation transactions. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| October 5, 2023 | 25% of the shares subject to the restricted stock unit award vested |
| 04/04/2025 | Date of transaction: exercise of restricted stock units and disposal of shares for tax obligations. |
| 04/07/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Stock Transactions, Restricted Stock Units, James Mock, Moderna, MRNA, CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.